Latest Market News

PointsBet’s board has unanimously recommended shareholders accept MIXI Australia’s increased $1.25 per share cash offer, now unconditional and representing a significant premium. MIXI holds 28.2% of PointsBet and may raise the offer further if it gains majority control.

Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.

FBR Limited has raised A$2 million through a share placement and purchase plan, complementing a $20 million subscription facility, to fund new robotic products, strategic partnerships, and debt repayment.

Rewardle Holdings Limited reported a 2.8% revenue increase to $9.68 million for FY24 but swung to a $3.44 million net loss, driven by rising expenses and associate losses. The company expanded its footprint with acquisitions in grocery delivery and fintech, while deepening its stake in AI-powered health tech partner CloudHolter.

Magnetite Mines Limited has updated its Razorback Iron Ore Project, revealing a 6.6 billion tonne mineral resource and progressing key strategic partnerships and approvals to support green steelmaking ambitions.

Magnetite Mines Limited has announced a renounceable rights issue to raise up to $2.65 million, aiming to fund critical development milestones for its Razorback Iron Ore Project and secure strategic partnerships for DFS funding.

Thunderbird Resources has addressed a recent spike in its share price and volume by releasing previously undisclosed survey results following a trading halt, reaffirming its compliance with ASX rules.

Elders Limited faces a regulatory delay from the ACCC on its acquisition of Delta Agribusiness but remains optimistic about the deal's benefits and completion timeline.

Iress Ltd confirms early-stage discussions with Blackstone and Thoma Bravo amid acquisition speculation, following a withdrawn A$10.50 per share offer from Blackstone.

TMK Energy has safely drilled and cased the LF-07 pilot well at its Gurvantes XXXV Coal Seam Gas Project, intersecting 54 metres of net coal and setting the stage for imminent production.

Neuren Pharmaceuticals has added SYNGAP1-related disorder to its NNZ-2591 development program following encouraging pre-clinical findings, targeting a rare condition with no approved treatments.

Greatland Resources has downgraded its FY26 gold production target and significantly increased capital expenditure forecasts for its Telfer Project, prompting a sharp share price reaction and detailed ASX disclosure.